RMC No. 81-2022: Loss of BIR Form No. 2524 Revenue Official Receipts and Immediate Verification Requirements

RMC No. 81-2022 notifies the loss and cancellation of certain BIR Form No. 2524 RORs. Businesses must verify affected transactions and treat cancelled receipts as invalid. Businesses and tax practitioners must urgently verify all transactions involving certain BIR Form No. 2524 โ€“ Revenue Official Receipts (ROR) that have been reported lost or cancelled. Failure to […]

RMC No. 58-2022: Updates to VAT-Exempt Medicines List Including Hypertension and COVID-19 Treatments

RMC No. 58-2022 publishes FDA corrections to VAT-exempt medicines, affecting hypertension and COVID-19 treatments. Businesses must update records and invoices to remain compliant. Businesses and healthcare providers must immediately note changes to the VAT-exempt status of certain medicines. RMC No. 58-2022 publishes the FDA’s updates correcting names of specific medicines used for hypertension and COVID-19 […]

RMC No. 57-2022: VAT Exemption Expanded to Include Hypertension, Diabetes, and COVID-19 Medicines

RMC No. 57-2022 updates the VAT-exempt list under the CREATE Act to include medicines for hypertension, diabetes, and COVID-19, requiring businesses to adjust invoicing and VAT reporting. Businesses and healthcare providers must immediately account for the updated VAT-exempt status of certain medicines for hypertension, diabetes, and COVID-19, effective from April 27, 2022. Failure to recognize […]